HARMONi-2 evaluated monotherapy ivonescimab against monotherapy pembrolizumab in patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) whose tumors have positive PD-L1 ...

Coller Capital appointed a new director for its private wealth team who recently finished up at L1 Capital. Alexander Ordon joined Coller Capital in March as a director for Australia and New Zealand ...

本文综述了抗 PD-1/PD-L1 免疫治疗后复发或转移性头颈部鳞状细胞癌（R/M HNSCC）的治疗策略。阐述了免疫治疗耐药的定义、机制，介绍了免疫治疗、化疗 ± 西妥昔单抗、靶向治疗、抗体偶联药物及双特异性抗体等治疗方案的研究现状，为后续治疗提供方向。

Before London, there was Londinium, the capital of Roman Britain, and although it was abandoned by AD 450, the influence and some remnants of the ancient city still remain. Join Pott’s as he ...

ASCENT-04 data showed sacituzumab govitecan plus pembrolizumab improved progression-free survival in PD-L1+ metastatic triple-negative breast cancer. The combination of sacituzumab govitecan-hziy ...

Full results from the Phase III ASCENT-04/KEYNOTE-D19 study demonstrated statistically significant and clinically meaningful survival benefits in patients with previously untreated, PD-L1-positive ...

Department of Nuclear Medicine, Fudan University Shanghai Cancer Center, Shanghai 200032, P.R. China Department of Nuclear Medicine, Cancer Institute, Fudan University Shanghai Cancer Center, Shanghai ...

Adams has added that he would be fine with an L1-centric scaling approach. This, however, would require "substantial tradeoffs." This comes after Bankless co-founder David Hoffman said that the ...

自动驾驶技术根据自动化程度的不同分为L0到L5六个级别。其中，L0级、L1级、L2级都只能称为辅助驾驶系统。谭待指出，2025年行业内和大众对Agent的定义可能会更加清晰，行业内或许会像自动驾驶分级一样，对Agent进行分级，如Agent L1、L2、L3、L4 这类。“那些开发 ...

4月14日，中国医学科学院肿瘤医院赫捷院士团队在Cell Press细胞出版社医学旗舰期刊Med，发表了题为“Efficacy and safety of anti-PD-1 versus anti-PD-L1 in perioperative immunotherapy: A comprehensive reanalysis of randomized controlled ...

L1 Capital defied a turbulent market by taking a timely bet against National Australia Bank stock, helping the Melbourne hedge fund with more than $6 billion in assets record an outsize gain over ...